Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Apyx Medical Corporation - Common Stock (NQ:APYX)

3.992 +0.122 (+3.14%)
Streaming Delayed Price Updated: 10:04 AM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
Apyx Medical: Q2 Earnings Insights
  Apyx Medical (NASDAQ:APYX) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Apyx Medical's Renuvion Scores FDA Approval To Eliminate Sagging Neck
 
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
Apyx Medical Posts Encouraging Data From Renuvion Device In Sagging Skin
 
Via Benzinga
Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Apyx Medical Corporation (APYX) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
APYX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
APYX FINAL DEADLINE ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
APYX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX
From Rosen Law Firm
Via Business Wire
Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet
From Apyx Medical Corporation
Via Business Wire
APYX FINAL DEADLINE ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Recap of Monday's Biotech Catalysts - End of the Day Summary
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least... 
Via Benzinga
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin
From Apyx Medical Corporation
Via Business Wire
APYX INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region
From Apyx Medical Corporation
Via Business Wire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - APYX
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022
From Apyx Medical Corporation
Via Business Wire
NASDAQ:APYX Investor Alert: Lawsuit Alleges Securities Laws Violations by Apyx Medical Corporation
San Diego, CA -- (SBWIRE) -- 06/21/2022 -- An investor, who purchased NASDAQ:APYX shares, filed a lawsuit against Apyx Medical Corporation over alleged Federal Securities Laws violations. 
Via SBWire
Apyx Medical Corporation Investor News: Robbins LLP is Investigating Apyx Medical Corporation (APYX) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of APYX Medical Corporation (APYX) Investors and Encourages Investors to Contact the Firm Before August 5, 2022
From Kirby McInerney LLP
Via Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)
From Law Offices of Howard G. Smith
Via Business Wire
APYX Shareholder News: Robbins LLP Reminds Investors of Class Action Against Apyx Medical Corporation (APYX)
From Robbins LLP
Via Business Wire
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)
From Glancy Prongay & Murray LLP
Via Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Apyx Medical Corporation (APYX)
From Robbins LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.